Skip to main content
. 2000 Jan;49(1):72–79. doi: 10.1046/j.1365-2125.2000.00104.x

Figure 3.

Figure 3

Averaged CAR middle latency changes over time after intravenous injection of 0.15 mg kg−1 midazolam (▪), α-hydroxy-midazolam (□), or placebo (○). Data are expressed as means of six healthy volunteers. The benzodiazepine time-effect curves were significantly different from the placebo curves (midazolam: P < 0.003, α-hydroxy-midazolam: P < 0.008; anova for repeated measures).